marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Halozyme Therapeutics Income Statement 2011-2024 | HALO
Annual Income Statement Halozyme Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.75 B | 6.84 B | 4.99 B | 6.16 B | 2.8 B | 2.3 B | 2.62 B | 1.44 B | 1.11 B | 1.75 B | 1.8 B | 788 M | 1.09 B |
Shares |
132 M | 137 M | 141 M | 136 M | 144 M | 144 M | 136 M | 128 M | 127 M | 123 M | 113 M | 111 M | 103 M |
Historical Prices |
36 | 50 | 35.5 | 45.2 | 19.6 | 17.2 | 19.7 | 12.8 | 8.13 | 15.1 | 14.1 | 5.45 | 11.5 |
Net Income |
282 M | 202 M | 403 M | 129 M | -72.2 M | -80.3 M | 63 M | -103 M | -32.2 M | -68.4 M | -83.5 M | -53.6 M | -19.8 M |
Revenue |
829 M | 660 M | 443 M | 268 M | 196 M | 152 M | 317 M | 147 M | 135 M | 75.3 M | 54.8 M | 42.3 M | 56.1 M |
Cost of Revenue |
192 M | 139 M | 81.4 M | 43.4 M | 45.5 M | 10.1 M | 31.2 M | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 150 M | 142 M | 285 M | 113 M | 106 M | 52.6 M | 48.6 M | 41.2 M | 55.8 M |
Operating Income |
338 M | 268 M | 276 M | 144 M | -67.6 M | -69.3 M | 81 M | -83.2 M | -27.5 M | -63 M | -80.4 M | -53.6 M | -19.8 M |
Interest Expense |
18.8 M | 16.9 M | 7.53 M | 20.4 M | 11.6 M | 18 M | 22 M | 20 M | 5.2 M | 5.58 M | 3.27 M | - | - |
EBITDA |
349 M | 274 M | 279 M | 148 M | -63.5 M | -66.9 M | 83.2 M | -80.8 M | -25.8 M | -61.3 M | -79.2 M | -52.5 M | -18.7 M |
Operating Expenses |
- | - | - | - | 218 M | 211 M | 204 M | 197 M | 133 M | 116 M | 129 M | 94.9 M | 75.7 M |
General and Administrative Expenses |
149 M | 144 M | 50.3 M | 45.7 M | 77.3 M | 60.8 M | 53.8 M | 45.9 M | 40 M | 35.9 M | 32.3 M | 24.8 M | 18.1 M |
All numbers in USD currency
Quarterly Income Statement Halozyme Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
127 M | 127 M | 127 M | 127 M | 132 M | 132 M | 135 M | 135 M | 137 M | 138 M | 138 M | 138 M | 142 M | 142 M | 138 M | 135 M | 137 M | 136 M | 137 M | 141 M | 146 M | 145 M | 145 M | 144 M | 144 M | 144 M | 143 M | 142 M | 141 M | 134 M | 129 M | 127 M | 128 M | 128 M | 128 M | 127 M | 127 M | 126 M | 125 M | 124 M | 124 M | 124 M | 119 M | 114 M | 113 M | 112 M | 112 M | 112 M | 112 M | 112 M | 108 M | 103 M | 103 M | 103 M | 101 M |
Net Income |
137 M | 93.2 M | 76.8 M | - | 81.8 M | 74.8 M | 39.6 M | - | 61.6 M | 22.7 M | 60.1 M | - | 217 M | 91.5 M | 27.9 M | 73.2 M | 36.2 M | 25.8 M | -6.1 M | -34.4 M | -25 M | -14.6 M | 1.8 M | -2.13 M | -27.8 M | -22.9 M | -27.5 M | 124 M | 2.75 M | -30.8 M | -32.9 M | -27.4 M | -28.9 M | -26.9 M | -19.8 M | -27.4 M | -28.9 M | -26.9 M | -19.8 M | -5.27 M | -20.3 M | -16.3 M | -26.5 M | -22 M | -19.3 M | -22.9 M | -19.3 M | -4.41 M | -20 M | -14 M | -15.1 M | -18.4 M | 5.17 M | 3.12 M | -9.64 M |
Revenue |
290 M | 231 M | 196 M | - | 216 M | 221 M | 162 M | - | 209 M | 152 M | 117 M | - | 116 M | 136 M | 89 M | 122 M | 65.3 M | 55.2 M | 25.4 M | 53.7 M | 46.2 M | 39.1 M | 56.9 M | 60.2 M | 25.6 M | 35.2 M | 30.9 M | 190 M | 63.7 M | 33.8 M | 29.6 M | 39 M | 31.9 M | 33.3 M | 42.5 M | 39 M | 20.8 M | 43.4 M | 18.7 M | 30.4 M | 14.6 M | 18.4 M | 12 M | 12.5 M | 16 M | 14.5 M | 11.8 M | 21.8 M | 5.33 M | 7.76 M | 7.44 M | 2.41 M | 22.9 M | 23.2 M | 7.54 M |
Cost of Revenue |
49.4 M | 39.6 M | 28.3 M | - | 54.8 M | 50.1 M | 35.2 M | - | 47.3 M | 33.9 M | 15.9 M | - | 18.6 M | 23 M | 18.2 M | - | 5.57 M | 5.74 M | 5.79 M | - | 22.3 M | 1.88 M | 4.65 M | - | 626 K | 836 K | 3.05 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.18 M | 3.48 M | 597 K | 2.36 M | 6.01 M | 6.87 M | 3.88 M | 3.74 M | 5.06 M | 5.64 M | 3.65 M | 3.75 M | 5.1 M | 5.26 M | 4.99 M | 3.89 M | 5.42 M | 4.2 M | 5.39 M | 5.18 M | 5.42 M | 4.2 M | 5.39 M | 5.18 M | 4 M | 4.48 M | 3.57 M | 3.05 M | 6.27 M | 9.34 M | 1.82 M | 769 K | 806 K | 489 K | 382 K | 117 K | - | - | - | - |
Operating Income |
163 M | 117 M | 95.5 M | - | 88.3 M | 94.5 M | 53.8 M | - | 83.3 M | 34.1 M | 75.7 M | - | 75.6 M | 93 M | 50.7 M | - | 40.3 M | 29.6 M | -3.22 M | - | -24.5 M | -14 M | 2.97 M | - | -25.5 M | -20.1 M | -23.7 M | - | 8.08 M | -25.5 M | -27.5 M | - | -22.7 M | -21.7 M | -16.2 M | - | -23.2 M | 4.23 M | -13.9 M | - | -19 M | -14.9 M | -25.2 M | - | -18.5 M | -22.1 M | -18.5 M | - | -20 M | -14 M | -15.1 M | - | 5.15 M | 3.1 M | -9.66 M |
Interest Expense |
6.47 M | 5.03 M | 4.51 M | - | 4.79 M | 3.19 M | 4.54 M | - | 7.51 M | 3.1 M | 1.76 M | - | 1.75 M | 1.75 M | 1.96 M | - | 4.99 M | 5 M | 5.35 M | - | 2.08 M | 2.61 M | 3.2 M | - | 4.29 M | 4.77 M | 5.23 M | - | 5.54 M | 5.54 M | 5.45 M | - | 5.25 M | 5.25 M | 3.88 M | - | 1.3 M | 1.3 M | 1.3 M | - | 1.38 M | 1.45 M | 1.38 M | - | 850 K | 849 K | 848 K | - | - | - | - | - | 12.4 K | 20.4 K | 23.9 K |
EBITDA |
166 M | 120 M | 98 M | - | 91 M | 97.3 M | 56.4 M | - | 85.3 M | 35.2 M | 76.4 M | - | 76.3 M | 93.8 M | 51.5 M | - | 41.1 M | 30.4 M | -2.37 M | - | -23.5 M | -13 M | 3.96 M | - | -24.9 M | -19.5 M | -23.1 M | - | 8.58 M | -24.9 M | -26.9 M | - | -22 M | -21.1 M | -15.7 M | - | -22 M | 5.05 M | -13.5 M | - | -17.7 M | -14.1 M | -24.8 M | - | -17.6 M | -21.5 M | -18.2 M | - | -19.2 M | -13.5 M | -14.9 M | - | 6 M | 3.71 M | -9.33 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44.1 M | 25 M | 25.7 M | 28.6 M | 85.7 M | 70.8 M | 53.1 M | 54 M | 60.3 M | 51 M | 55.3 M | 54.6 M | 63.6 M | 55.7 M | 59.2 M | 57.1 M | 61.6 M | 54.6 M | 55.1 M | 58.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
41.2 M | 35.7 M | 35.1 M | - | 35.3 M | 38.9 M | 37.4 M | - | 34.5 M | 57.5 M | 13.8 M | - | 13.2 M | 12.3 M | 11.1 M | - | 11.7 M | 11 M | 12.6 M | - | 18 M | 17.3 M | 18 M | - | 14.9 M | 14.4 M | 13.6 M | - | 13.3 M | 13.1 M | 12.6 M | - | 11.6 M | 11.2 M | 10.8 M | - | 10.2 M | 9.81 M | 9.4 M | - | 8.59 M | 8.75 M | 10.2 M | - | 8.14 M | 7.3 M | 7.56 M | - | 5.63 M | 5.58 M | 6.62 M | - | 4.26 M | 4.57 M | 3.41 M |
All numbers in USD currency